Skip to main content
Clinical Trials/NCT05988060
NCT05988060
Recruiting
N/A

The Effect of Physical Exercise During Radiotherapy on Physical Functioning in Patients With Head and Neck Cancer: a Trial Within Cohorts, the VITAL Study

Institute Verbeeten1 site in 1 country112 target enrollmentNovember 9, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Institute Verbeeten
Enrollment
112
Locations
1
Primary Endpoint
physical performance
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this trial within cohorts study is to determine and compare physical performance, muscle strength, fatigue, quality of life, body composition, nutritional status, physical activity, treatment tolerability of radiotherapy (RT), chemoradiation (CRT) or bioradiation (BRT), and healthcare related costs in patients with head and neck cancer (HNC) with and without a 10 week physical exercise intervention (PEI) during RT, CRT or BRT ((C/B)RT).

Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI twice a week for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT.

Researchers will compare patients who undergo the PEI with patients who did not undergo the PEI to see if there is difference in physical performance, muscle strength, fatigue, Quality of Life, body composition, nutritional status, physical activity, treatment tolerability of (C/B)RT , and healthcare related costs in patients with Head and Neck Cancer (HNC) with and without a 10 week Physical Exercise Intervention (PEI) during (C/B)RT).

Registry
clinicaltrials.gov
Start Date
November 9, 2022
End Date
November 9, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Institute Verbeeten
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients with HNC who are scheduled for (C/B)RT,
  • ≥18 years of age,
  • sufficient Dutch writing and reading skills,
  • a Karnofsky performance status (KPS) \>60,
  • able to walk ≥60m without a mobility aid, and
  • no contraindication for physical activity as measured with the physical activity readiness questionnaire (PAR-Q).

Exclusion Criteria

  • recurrence of HNC and/or
  • secondary HNC.

Outcomes

Primary Outcomes

physical performance

Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

six minute walking test

Secondary Outcomes

  • Fatigue(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))
  • Muscle strength(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))
  • socio-demographic data and medical data(M0 (baseline/before (C/B)RT))
  • Health Related Quality of Life(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))
  • Nutrition status(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))
  • Tolerability of radiotherapy, chemoradiation or bioradiation(M1 (12 weeks), M2 (6 months), M3 (12 months))
  • Body composition(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))
  • Physical activity(M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months))

Study Sites (1)

Loading locations...

Similar Trials